Home brain stimulation during sleep for people with mild cognitive impairment
Tests gentle brain stimulation at night to deepen sleep and memory in mild cognitive impairment.
Key facts
- Who runs it
- Brain Electrophysiology Laboratory Company
- Where
- Eugene and Winston-Salem, United StatesSee the 2 sites
- Trial code
- Registry title
- Home Sleep Therapy for Older Adults With MCI
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 8 Feb 2023
- Planned end
- 1 Jun 2026
- Type of study
- Interventional
- Treatments tested
- Transcranial Electrical Stimulation
- Record updated
- 17 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for older adults with amnestic mild cognitive impairment (memory-related thinking problems), and healthy volunteers without it. It tests a home device that gives gentle electrical brain stimulation during sleep.
- Age
- People with amnestic MCI: 55-85 years old. Healthy volunteers without MCI: 40-80 years old.
- Sex
- All sexes can join.
- Disease stage
- Amnestic mild cognitive impairment (MCI), or healthy volunteers without MCI.
- Earlier treatment
- People who have had Electroconvulsive Therapy (ECT) cannot join.
Main reasons for not taking part
- History of seizures, epilepsy, stroke, or moderate or severe brain injury, including brain surgery
- Significant neurological disease such as Parkinson
- Severe insomnia, untreated sleep apnea, severe anxiety or depression, or active suicidal thoughts
- Metal in the head, implants or a medication infusion device
- Pregnancy, medications that may affect the EEG, or allergy to lidocaine or silver
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- For participant with Amnestic MCI, the inclusion age range is 55-85 years old
- For healthy volunteers without MCI, the inclusion age range is 40-80 years old
Who cannot take part
- Medications that may affect the EEG
- Presence of metal in head or implants or medication infusion device
- History of seizures
- History of epilepsy
- History of mod/severe brain injury or trauma (including neurosurgery)
- History or presence of significant neurological disease such as Parkinson
- History of Electroconvulsive Therapy (ECT)
- History of stroke
- Sensitivity or allergy to lidocaine or silver
- Presence of severe insomnia
- Presence of untreated sleep apnea
- Presence of severe anxiety or depression
- Presence of active suicidal ideation
- Pregnancy
- Adverse reaction to TMS
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
This trial is currently available in United States.
- Brain Electrophysiology Laboratory CompanyEugene, United StatesContact: Don M Tucker, PhDTaking people
- Wake Forest UniversityWinston-Salem, United StatesContact: Ruth Benca, PhDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in people with mild cognitive impairment via home use sleep therapy device (SleepWISP) as well as learn about biomarkers associated with Alzheimer disease (AD). The clinical trial aims to answer the following main questions:
Read full original descriptionShow less
1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could enhance deep sleep over multiple nights in the target population. 3. Whether enhance on deep sleep could improve memory performance in the target population.
Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep along with an actigraphy watch that measures their movement throughout the day. In addition, blood samples or nasal swab assays will be collected from participants multiple times during the study.
The group in the trial
- Deep Sleep Enhancement with TESTreatment being tested
Transcranial Electrical Stimulation, 0.5 Hz sine wave, 0.5 mA, between frontal (frontopolar and inferior lateral frontal) and posterior (mastoid and occipital) electrodes.
Treatment: Transcranial Electrical Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Home Sleep Therapy System for Mild Cognitive Impairment
- Plain-language title
- Home brain stimulation during sleep for people with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05771844, who can take part
- Record updated
- 17 February 2025